Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1140406]Brief description This project will determine if new immune inhibitory checkpoints can be synergistically targeted with BRAFV600E inhibition to reactivate and allow NK cells to maximise their anti-tumour immune functions and prevent cancer spread. It is a completely novel approach that will allow for the more rational design of melanoma treatments that targets NK cells following surgery and local radiotherapy and/or chemotherapy.
Funding Amount $AUD 450,647.26
Funding Scheme Project Grants
Notes New Investigator Grant
- nhmrc : 1140406
- PURL : https://purl.org/au-research/grants/nhmrc/1140406
